Literature DB >> 16417378

Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors.

Howard Bregman1, Patrick J Carroll, Eric Meggers.   

Abstract

An important objective for the discovery of compounds with unique biological activities is the development of methods for the synthesis of molecular scaffolds with defined three-dimensional shapes. We are currently investigating the scope of using metal complexes to accomplish this goal. In these compounds, the metal center has the role of organizing the orientation of the organic ligands, thus defining the overall shape of the molecule. A strategy is presented that allows a rapid scanning of ligands around a ruthenium center in the search for ligand spheres that are complementary in shape and functional group presentation to ATP binding sites of protein kinases. Following this approach, we have identified octahedral ruthenium complexes as potent inhibitors for the protein kinases Pim1, MSK1, and GSK3alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417378     DOI: 10.1021/ja055523r

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  30 in total

1.  Conformational landscape of platinum(II)-tetraamine complexes: DFT and NBO studies.

Authors:  Austin B Yongye; Marc A Giulianotti; Adel Nefzi; Richard A Houghten; Karina Martínez-Mayorga
Journal:  J Comput Aided Mol Des       Date:  2010-03-24       Impact factor: 3.686

2.  Regression of Dalton's lymphoma in vivo via decline in lactate dehydrogenase and induction of apoptosis by a ruthenium(II)-complex containing 4-carboxy N-ethylbenzamide as ligand.

Authors:  Raj K Koiri; Surendra K Trigun; Lallan Mishra; Kiran Pandey; Deobrat Dixit; Santosh K Dubey
Journal:  Invest New Drugs       Date:  2008-11-29       Impact factor: 3.850

3.  Enzyme microarrays assembled by acoustic dispensing technology.

Authors:  E Y Wong; S L Diamond
Journal:  Anal Biochem       Date:  2008-06-20       Impact factor: 3.365

4.  Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

Authors:  Sebastian Blanck; Thomas Cruchter; Adina Vultur; Radostan Riedel; Klaus Harms; Meenhard Herlyn; Eric Meggers
Journal:  Organometallics       Date:  2011-07-18       Impact factor: 3.876

5.  The art of filling protein pockets efficiently with octahedral metal complexes.

Authors:  Sebastian Blanck; Jasna Maksimoska; Julia Baumeister; Klaus Harms; Ronen Marmorstein; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-01       Impact factor: 15.336

6.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

7.  Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors.

Authors:  Li Feng; Yann Geisselbrecht; Sebastian Blanck; Alexander Wilbuer; G Ekin Atilla-Gokcumen; Panagis Filippakopoulos; Katja Kräling; Mehmet Ali Celik; Klaus Harms; Jasna Maksimoska; Ronen Marmorstein; Gernot Frenking; Stefan Knapp; Lars-Oliver Essen; Eric Meggers
Journal:  J Am Chem Soc       Date:  2011-03-29       Impact factor: 15.419

8.  From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.

Authors:  Nicholas Pagano; Eric Y Wong; Tom Breiding; Haidong Liu; Alexander Wilbuer; Howard Bregman; Qi Shen; Scott L Diamond; Eric Meggers
Journal:  J Org Chem       Date:  2009-12-04       Impact factor: 4.354

9.  Synthesis and cyclometalation of a pyrido[3,2-e]-2,10b-diaza-cyclopenta[c]fluorene-1,3-dione scaffold.

Authors:  Seann P Mulcahy; Patrick J Carroll; Eric Meggers
Journal:  Tetrahedron Lett       Date:  2006-12-11       Impact factor: 2.415

Review 10.  Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.

Authors:  Sébastien Deslandes; Stefan Chassaing; Evelyne Delfourne
Journal:  Mar Drugs       Date:  2009-12-01       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.